Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Toxicol Sci
2020 Jun 01;1752:236-250. doi: 10.1093/toxsci/kfaa036.
Show Gene links
Show Anatomy links
Targeted Pathway-based In Vivo Testing Using Thyroperoxidase Inhibition to Evaluate Plasma Thyroxine as a Surrogate Metric of Metamorphic Success in Model Amphibian Xenopus laevis.
Haselman JT
,
Olker JH
,
Kosian PA
,
Korte JJ
,
Swintek JA
,
Denny JS
,
Nichols JW
,
Tietge JE
,
Hornung MW
,
Degitz SJ
.
???displayArticle.abstract???
Chemical safety evaluation is in the midst of a transition from traditional whole-animal toxicity testing to molecular pathway-based in vitro assays and in silico modeling. However, to facilitate the shift in reliance on apical effects for risk assessment to predictive surrogate metrics having characterized linkages to chemical mechanisms of action, targeted in vivo testing is necessary to establish these predictive relationships. In this study, we demonstrate a means to predict thyroid-related metamorphic success in the model amphibian Xenopus laevis using relevant biochemical measurements during early prometamorphosis. The adverse outcome pathway for thyroperoxidase inhibition leading to altered amphibian metamorphosis was used to inform a pathway-based in vivo study design that generated response-response relationships. These causal relationships were used to develop Bayesian probabilistic network models that mathematically determine conditional dependencies between biochemical nodes and support the predictive capability of the biochemical profiles. Plasma thyroxine concentrations were the most predictive of metamorphic success with improved predictivity when thyroid gland sodium-iodide symporter gene expression levels (a compensatory response) were used in conjunction with plasma thyroxine as an additional regressor. Although thyroid-mediated amphibian metamorphosis has been studied for decades, this is the first time a predictive relationship has been characterized between plasma thyroxine and metamorphic success. Linking these types of biochemical surrogate metrics to apical outcomes is vital to facilitate the transition to the new paradigm of chemical safety assessments.
Ankley,
Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment.
2010, Pubmed
Ankley,
Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment.
2010,
Pubmed
Axelstad,
Developmental neurotoxicity of propylthiouracil (PTU) in rats: relationship between transient hypothyroxinemia during development and long-lasting behavioural and functional changes.
2008,
Pubmed
Beech,
The role of thyroidal type-I iodothyronine deiodinase in tri-iodothyronine production by human and sheep thyrocytes in primary culture.
1993,
Pubmed
Brown,
The role of deiodinases in amphibian metamorphosis.
2005,
Pubmed
,
Xenbase
Brown,
Amphibian metamorphosis.
2007,
Pubmed
,
Xenbase
Buckalew,
Evaluation of potential sodium-iodide symporter (NIS) inhibitors using a secondary Fischer rat thyroid follicular cell (FRTL-5) radioactive iodide uptake (RAIU) assay.
2020,
Pubmed
Coady,
Evaluation of the amphibian metamorphosis assay: exposure to the goitrogen methimazole and the endogenous thyroid hormone L-thyroxine.
2010,
Pubmed
,
Xenbase
Degitz,
Progress towards development of an amphibian-based thyroid screening assay using Xenopus laevis. Organismal and thyroidal responses to the model compounds 6-propylthiouracil, methimazole, and thyroxine.
2005,
Pubmed
,
Xenbase
Deisenroth,
Development of an In Vitro Human Thyroid Microtissue Model for Chemical Screening.
2020,
Pubmed
Deme,
Specificity of thyroid hormone synthesis. The role of thyroid peroxidase.
1978,
Pubmed
Dong,
Development of a non-radioactive screening assay to detect chemicals disrupting the human sodium iodide symporter activity.
2019,
Pubmed
Fort,
The hypothalamic-pituitary-thyroid (HPT) axis in frogs and its role in frog development and reproduction.
2007,
Pubmed
,
Xenbase
Gilbert,
Developmental thyroid hormone disruption: prevalence, environmental contaminants and neurodevelopmental consequences.
2012,
Pubmed
Gilbert,
Impact of low-level thyroid hormone disruption induced by propylthiouracil on brain development and function.
2011,
Pubmed
Hallinger,
Development of a screening approach to detect thyroid disrupting chemicals that inhibit the human sodium iodide symporter (NIS).
2017,
Pubmed
Hassan,
Neurodevelopment and Thyroid Hormone Synthesis Inhibition in the Rat: Quantitative Understanding Within the Adverse Outcome Pathway Framework.
2017,
Pubmed
Hassan,
Extrapolating In Vitro Screening Assay Data for Thyroperoxidase Inhibition to Predict Serum Thyroid Hormones in the Rat.
2020,
Pubmed
Hornung,
Screening the ToxCast Phase 1 Chemical Library for Inhibition of Deiodinase Type 1 Activity.
2018,
Pubmed
Hornung,
In Vitro, Ex Vivo, and In Vivo Determination of Thyroid Hormone Modulating Activity of Benzothiazoles.
2015,
Pubmed
,
Xenbase
Hothorn,
Simultaneous inference in general parametric models.
2008,
Pubmed
Kessler,
Factors influencing the study of peroxidase-generated iodine species and implications for thyroglobulin synthesis.
2008,
Pubmed
Lewis,
Improving epidemiologic data analyses through multivariate regression modelling.
2013,
Pubmed
Morvan-Dubois,
Xenopus laevis as a model for studying thyroid hormone signalling: from development to metamorphosis.
2008,
Pubmed
,
Xenbase
Murk,
Mechanism-based testing strategy using in vitro approaches for identification of thyroid hormone disrupting chemicals.
2013,
Pubmed
Noyes,
Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches.
2019,
Pubmed
Olker,
Screening the ToxCast Phase 1, Phase 2, and e1k Chemical Libraries for Inhibitors of Iodothyronine Deiodinases.
2019,
Pubmed
Olker,
Evaluating Iodide Recycling Inhibition as a Novel Molecular Initiating Event for Thyroid Axis Disruption in Amphibians.
2018,
Pubmed
,
Xenbase
Paul,
Cross-species analysis of thyroperoxidase inhibition by xenobiotics demonstrates conservation of response between pig and rat.
2013,
Pubmed
Paul,
Development of a thyroperoxidase inhibition assay for high-throughput screening.
2014,
Pubmed
Paul Friedman,
Tiered High-Throughput Screening Approach to Identify Thyroperoxidase Inhibitors Within the ToxCast Phase I and II Chemical Libraries.
2016,
Pubmed
Paul-Friedman,
Limited Chemical Structural Diversity Found to Modulate Thyroid Hormone Receptor in the Tox21 Chemical Library.
2019,
Pubmed
Ruf,
Structural and functional aspects of thyroid peroxidase.
2006,
Pubmed
Sachs,
Frogs model man: In vivo thyroid hormone signaling during development.
2017,
Pubmed
,
Xenbase
Shah,
Using ToxCast™ Data to Reconstruct Dynamic Cell State Trajectories and Estimate Toxicological Points of Departure.
2016,
Pubmed
Shi,
Tadpole competence and tissue-specific temporal regulation of amphibian metamorphosis: roles of thyroid hormone and its receptors.
1996,
Pubmed
,
Xenbase
Sternberg,
Control of pituitary thyroid-stimulating hormone synthesis and secretion by thyroid hormones during Xenopus metamorphosis.
2011,
Pubmed
,
Xenbase
Tata,
Amphibian metamorphosis as a model for the developmental actions of thyroid hormone.
2006,
Pubmed
,
Xenbase
Taurog,
Mechanism of simultaneous iodination and coupling catalyzed by thyroid peroxidase.
1996,
Pubmed
Tietge,
Early temporal effects of three thyroid hormone synthesis inhibitors in Xenopus laevis.
2010,
Pubmed
,
Xenbase
Tietge,
Metamorphic inhibition of Xenopus laevis by sodium perchlorate: effects on development and thyroid histology.
2005,
Pubmed
,
Xenbase
Tietge,
Inhibition of the thyroid hormone pathway in Xenopus laevis by 2-mercaptobenzothiazole.
2013,
Pubmed
,
Xenbase
Wang,
High-Throughput Screening and Quantitative Chemical Ranking for Sodium-Iodide Symporter Inhibitors in ToxCast Phase I Chemical Library.
2018,
Pubmed
Wegner,
Identifying reference chemicals for thyroid bioactivity screening.
2016,
Pubmed
Zoeller,
Mode of action: developmental thyroid hormone insufficiency--neurological abnormalities resulting from exposure to propylthiouracil.
2005,
Pubmed